Addex Therapeutics (ADXN) EBITDA Margin (2019 - 2025)
Addex Therapeutics (ADXN) posted EBITDA Margin of -313364.92% for Q4 2025, down 132251.06 percentage points from -181113.86% a year earlier and down 311029.91 percentage points from the prior quarter.
Powered by 
Analysis
Addex Therapeutics (ADXN) EBITDA Margin (2019 - 2025) Analysis & Trends
For FY2025, Addex Therapeutics' EBITDA Margin came in at -9362.49%, down 8686.94 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -9034.09 percentage points (FY2020 to FY2025).
- In prior years, Addex Therapeutics' EBITDA Margin was -675.55% in FY2024 (-555.46 pp), -120.09% in FY2023 (+598.24 pp), -718.33% in FY2022 (-198.55 pp) and -519.78% in FY2021 (-191.38 pp).
- The Q4 2025 figure stands as the lowest quarterly EBITDA Margin in data going back to Q1 2019.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2021, with a gain of 10543.51 percentage points; the weakest was Q4 2024, with a drop of 179703.89 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Addex Therapeutics | 3.65 Mn | -3.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -313,364.92% |
| Sep 30, 2025 | -2,335.01% |
| Mar 31, 2025 | -1,668.86% |
| Dec 31, 2024 | -27,972.35% |
| Sep 30, 2024 | -858.84% |
| Jun 30, 2024 | -774.81% |
| Mar 31, 2024 | -304.98% |
| Dec 31, 2023 | -423.92% |
| Sep 30, 2023 | -247.70% |
| Jun 30, 2023 | -369.77% |
| Mar 31, 2023 | -56.11% |
| Dec 31, 2022 | -3,450.93% |
| Sep 30, 2022 | -1,025.36% |
| Jun 30, 2022 | -3,775.33% |
| Mar 31, 2022 | -2,379.66% |
| Dec 31, 2021 | -489.15% |
| Sep 30, 2021 | -511.45% |
| Jun 30, 2021 | -445.13% |
| Mar 31, 2021 | -362.39% |
| Dec 31, 2020 | -313.38% |
API Access
Addex Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ADXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ADXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();